Healthcare IT – Flow CytometryLOCATIONS
Boston, MAWEBSITE EXITED
Union Biometrica has a proprietary system for sorting microscopic objects based on fluorescent parameters for drug discovery.
Brook was an early stage investor in Union Biometrica and was active in evaluating and hiring several key hires for the Company. Union Biometrica invented novel technology to aid in identifying genes used in disease relevance and drug discovery. The business was successfully sold to Harvard Biosciences.